Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.
Renner M, Flanagan A, Dejnirattisai W, Puttikhunt C, Kasinrerk W, Supasa P, Wongwiwat W, Chawansuntati K, Duangchinda T, Cowper A, Midgley CM, Malasit P, Huiskonen JT, Mongkolsapaya J, Screaton GR, Grimes JM. Renner M, et al. Among authors: chawansuntati k. Nat Immunol. 2018 Nov;19(11):1248-1256. doi: 10.1038/s41590-018-0227-7. Epub 2018 Oct 15. Nat Immunol. 2018. PMID: 30323338 Free PMC article.
Cross-reacting antibodies enhance dengue virus infection in humans.
Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G. Dejnirattisai W, et al. Among authors: chawansuntati k. Science. 2010 May 7;328(5979):745-8. doi: 10.1126/science.1185181. Science. 2010. PMID: 20448183 Free PMC article.
Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.
Midgley CM, Flanagan A, Tran HB, Dejnirattisai W, Chawansuntati K, Jumnainsong A, Wongwiwat W, Duangchinda T, Mongkolsapaya J, Grimes JM, Screaton GR. Midgley CM, et al. Among authors: chawansuntati k. J Immunol. 2012 May 15;188(10):4971-9. doi: 10.4049/jimmunol.1200227. Epub 2012 Apr 9. J Immunol. 2012. PMID: 22491255 Free PMC article.
Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
Yasamut U, Thongkum W, Moonmuang S, Sakkhachornphop S, Chaiwarith R, Praparattanapan J, Wipasa J, Chawansuntati K, Supparatpinyo K, Lai E, Tayapiwatana C. Yasamut U, et al. Among authors: chawansuntati k. Front Immunol. 2019 Aug 14;10:1905. doi: 10.3389/fimmu.2019.01905. eCollection 2019. Front Immunol. 2019. PMID: 31474987 Free PMC article.
Diagnostic performance between in-house and commercial SARS-CoV-2 serological immunoassays including binding-specific antibody and surrogate virus neutralization test (sVNT).
Winichakoon P, Wipasa J, Chawansuntati K, Salee P, Sudjaritruk T, Yasri S, Khamwan C, Peerakam R, Dankai D, Chaiwarith R. Winichakoon P, et al. Among authors: chawansuntati k. Sci Rep. 2023 Jan 2;13(1):34. doi: 10.1038/s41598-022-26202-1. Sci Rep. 2023. PMID: 36593231 Free PMC article.
A preliminary study on the effectiveness of maternal to neonatal transfer of antibodies against SARS-CoV-2 in the women vaccinated with heterologous CoronaVac-ChAdOx1.
Pongsatha S, Tongsong T, Wipasa J, Sakkhachornphop S, Hongjaisee S, Chawansuntati K. Pongsatha S, et al. Among authors: chawansuntati k. Hum Vaccin Immunother. 2023 Dec 31;19(1):2196912. doi: 10.1080/21645515.2023.2196912. Epub 2023 Apr 14. Hum Vaccin Immunother. 2023. PMID: 37057690 Free PMC article.
29 results